Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

Source:http://linkedlifedata.com/resource/pubmed/id/17012043

Download in:

View as

General Info

PMID
17012043